MAM
Bytedance elevates Abhishek Karwar to head of global creative & emerging markets – user growth
NEW DELHI: TikTok developer Bytedance has elevated Abhishek Karwar to head of global creative and emerging markets – user growth. Karwar had joined the organisation in December 2019 as head of user growth.
During his two decades in the media and entertainment industry, Karwar has experience managing and scaling up digital businesses and heading product development, marketing and product marketing functions on a global level. He is well-versed in building platforms, negotiating partnership deals and executing go to market strategies.
The NIIT graduate considers his specialities to be in the field of short format videos, OTT technologies, digital media, broadcast media, business strategy.
Prior to his role at TikTok, Karwar had a brief stint as head of sales and marketing at Intuition Intelligence. He has also been associated with Mirriad, Zee Entertainment Enterprises, Times Group and ITC Infotech.
Karwar’s elevation comes at a time when Bytedance is downsizing its workforce in India after a months-long ban on its moneymaker, TikTok. Undeterred by this short-lived foray in one of its biggest markets, the Chinese app developer is expanding its operations worldwide, and has particularly ramped up recruitment in Singapore. The Beijing-headquartered company has also come under global scrutiny over TikTok’s data collection practices.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
